Cargando…

A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights

BACKGROUND: Tumor Treating Fields (TTFields) is a non-invasive modality for cancer treatment that utilizes a specific sinusoidal electric field ranging from 100 kHz to 300 kHz, with an intensity of 1 V/cm to 3 V/cm. Its purpose is to inhibit cancer cell proliferation and induce cell death. Despite p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xing, Liu, Kaida, Xing, Lidong, Rubinsky, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476910/ https://www.ncbi.nlm.nih.gov/pubmed/37665740 http://dx.doi.org/10.2478/raon-2023-0044

Ejemplares similares

Evaluating the therapeutic effect of tumor treating fields (TTFields) by monitoring the impedance across TTFields electrode arrays
por: Li, Xing, et al.
Publicado: (2022)

In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
por: Blatt, Roni, et al.
Publicado: (2021)

Temperature and Impedance Variations During Tumor Treating Fields (TTFields) Treatment
por: Gentilal, Nichal, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
por: Vergote, Ignace, et al.
Publicado: (2023)

Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields])
por: Shams, Shadi, et al.
Publicado: (2022)

Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
por: Kessler, Almuth F., et al.
Publicado: (2018)

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
por: Porat, Yaara, et al.
Publicado: (2017)

First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis
por: Kassubek, Rebecca, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo
por: Davidi, Shiri, et al.
Publicado: (2022)

The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
por: Oberheim-Bush, Nancy Ann, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo
por: Salvador, Ellaine, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
por: Fishman, Hila, et al.
Publicado: (2023)

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2020)

Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
por: Giladi, Moshe, et al.
Publicado: (2017)

AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
por: Shteingauz, Anna, et al.
Publicado: (2018)

Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Actin Dynamics
por: Voloshin, Tali, et al.
Publicado: (2020)

The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy
por: Tanzhu, Guilong, et al.
Publicado: (2022)

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
por: Ballo, Matthew T., et al.
Publicado: (2023)

Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data
por: Goldman, Stewart, et al.
Publicado: (2022)

Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs
por: Kirson, Eilon D., et al.
Publicado: (2009)

Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2021)

An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19
por: Farmani, Ahmad Reza, et al.
Publicado: (2021)

Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)
por: Nickl, Vera, et al.
Publicado: (2022)

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region
por: Anadkat, Milan J., et al.
Publicado: (2023)

Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas – a planning study
por: Straube, Christoph, et al.
Publicado: (2018)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020)

Tumour-treating fields (TTFields): Investigations on the mechanism of action by electromagnetic exposure of cells in telophase/cytokinesis
por: Berkelmann, Lukas, et al.
Publicado: (2019)

Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model
por: Barsheshet, Yiftah, et al.
Publicado: (2022)

Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment
por: Lee, Yeon-Joo, et al.
Publicado: (2020)

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2021)

Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier
por: Salvador, Ellaine, et al.
Publicado: (2023)

DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells
por: Vanderlinden, Aurelie, et al.
Publicado: (2023)

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2022)

Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)
por: Kirson, Eilon D, et al.
Publicado: (2009)

LMAP-12 TUMOR TREATING FIELDS (TTFIELDS) REAL-WORLD EXPERIENCE IN NEWLY DIAGNOSED GLIOBLASTOMA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF OVERALL SURVIVAL
por: Ballo, Matthew T, et al.
Publicado: (2023)

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
por: Voloshin, Tali, et al.
Publicado: (2020)

TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh, et al.
Publicado: (2019)

Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma
por: Sarkari, Akshat, et al.
Publicado: (2023)

Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
Publicado: (2022)

COVD-04. REAL-WORLD PERSPECTIVES: TUMOR TREATING FIELDS (TTFIELDS) UTILITY TO OPTIMIZE TREATMENT OF PATIENTS WITH GLIOBLASTOMA (GBM) AMIDST COVID-19 PANDEMIC
por: Frongillo, Peggy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0t1rqq4kpkmse9ms51n5q5iboq